Sara Nik

Item: Sara Nik
Rating: 2.91
Author: StockAnalysis.com

Stock Analyst at HC Wainwright & Co.

(2.91)

# 1,702

Out of 5,031 analysts

Total ratings

80%

Success rate

24.13%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CDTX Cidara Therapeutics	Maintains: Buy	$110 → $150	$101.52	+47.75%	3	Oct 9, 2025
	MBRX Moleculin Biotech	Reiterates: Buy	$4	$0.51	+684.31%	2	Sep 10, 2025

Cidara Therapeutics

Oct 9, 2025

Maintains: Buy

Price Target: $110 → $150

Current: $101.52

Upside: +47.75%

Moleculin Biotech

Sep 10, 2025

Reiterates: Buy

Price Target: $4

Current: $0.51

Upside: +684.31%